Skip to page content Skip to site navigation
Home :: Open Government :: News :: 2012 :: January
AG Chris Koster | FAQs
Missouri Attorney General


Browse by month and year

Search by keyword(s)

Attorney General's News Release

January 31, 2012

Attorney General Koster announces antitrust settlement with pharmaceutical companies

Jefferson City, Mo. – Attorney General Chris Koster announced today that Missouri and 32 other states have settled antitrust claims against pharmaceutical companies Aventis and Ferring. Missouri will receive $78,971.37 from the settlement.

Aventis manufactures and markets a prescription drug owned by Ferring called DDAVP (desmopressin), which is used for the treatment of diabetes and bed-wetting. The two companies allegedly delayed a competitor, Barr Laboratories, from selling generic versions of DDAVP by making materially misleading statements to the U.S. Patent Office.

“These companies tried to maintain a monopoly on DDAVP,” Koster said. “Whenever a generic substitute is unlawfully delayed, the result is higher co-pays for consumers and insurers paying for drugs.”

State homepage   |    Missouri statutes   |    Forms   |    Site Map   |    Accessibility   |    Privacy Policy   |    Contact Us  Follow AGO on Twitter!  RSS Feed  RSS Feed